Fig. 2
From: Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
Primary analysis hazard ratios for (A) vertebral fracture (Vert. Fracture), (B) atypical femoral fracture (AFF), (C) esophageal cancer (Eso. Cancer), and (D) osteonecrosis of jaw (ONJ). More precise estimates have greater opacity. Missing HR from data sources with 0 raloxifene events.
